Reinventing the small molecule toolbox: from proteins to RNA
Dark Matter Blog
APRIL 4, 2023
The bulk of my nearly three decades of experience up to that point was with drugging protein targets using a variety of modalities, but principally small molecules. Each yielded some insights; for example, fragment screening gave good hits, but advancing them against the conformational dynamism of RNA was problematic.
52 
Let's personalize your content